DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▲ |
---|---|---|---|---|---|
C0032285 | Pneumonia | CLEC1B | 51266 | C-type lectin domain family 1 member B | Q9P126 |
C0040034 | Thrombocytopenia | CLEC1B | 51266 | C-type lectin domain family 1 member B | Q9P126 |
C0279702 | Conventional (Clear Cell) Renal Cell Carcinoma | CLEC1B | 51266 | C-type lectin domain family 1 member B | Q9P126 |
C0024623 | Malignant neoplasm of stomach | CLEC1B | 51266 | C-type lectin domain family 1 member B | Q9P126 |
C0025202 | melanoma | CLEC1B | 51266 | C-type lectin domain family 1 member B | Q9P126 |
C2931019 | Split hand foot deformity 1 | CLEC1B | 51266 | C-type lectin domain family 1 member B | Q9P126 |
C1861172 | Venous Thromboembolism | CLEC1B | 51266 | C-type lectin domain family 1 member B | Q9P126 |
C0010068 | Coronary heart disease | CLEC1B | 51266 | C-type lectin domain family 1 member B | Q9P126 |
C0242584 | Autoimmune thrombocytopenia | CLEC1B | 51266 | C-type lectin domain family 1 member B | Q9P126 |
C0035222 | Respiratory Distress Syndrome, Adult | CLEC1B | 51266 | C-type lectin domain family 1 member B | Q9P126 |
C2239176 | Liver carcinoma | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
C0027651 | Neoplasms | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
C0006826 | Malignant Neoplasms | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
C0546837 | Malignant neoplasm of esophagus | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
C0152018 | Esophageal carcinoma | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
C1848296 | DOSAGE-SENSITIVE SEX REVERSAL | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
C0009402 | Colorectal Carcinoma | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
C1333762 | Gastric Cardia Adenocarcinoma | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
C0278701 | Gastric Adenocarcinoma | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
C1306459 | Primary malignant neoplasm | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
C0017668 | Focal glomerulosclerosis | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
C0268237 | Cytochrome-c Oxidase Deficiency | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
C0039483 | Giant Cell Arteritis | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
C0019100 | Severe Dengue | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
C0014859 | Esophageal Neoplasms | PLCE1 | 51196 | phospholipase C epsilon 1 | Q9P212 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024